Hoberman Kenneth
CIK 0001573722 Name as filed on the most recent filing
Filed as Hoberman Kenneth (30)
45 transaction lines · from 30 filings · filed 2013-11-27 to 2022-05-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
45 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-05-12 |
Nuvectis Pharma, Inc. NVCT |
P, Open-market purchase | 6,000 acquired | 17.40 | 104,400.00 | Form 4, filing 0001104659-22-060913 | |
| 2020-03-10 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 16,704 disposed | 4.91 | 82,016.64 | Form 4, filing 0001104659-20-033491 | |
| 2020-03-09 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 9,487 disposed | 5.08 | 48,193.96 | Form 4, filing 0001104659-20-033491 | |
| 2020-02-25 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 11,547 disposed | 6.42 | 74,131.74 | Form 4, filing 0001104659-20-027397 | |
| 2020-01-22 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 22,139 disposed | 7.02 | 155,415.78 | Form 4, filing 0001104659-20-006882 | |
| 2020-01-08 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 13,228 disposed | 10.37 | 137,174.36 | Form 4, filing 0001104659-20-003149 | |
| 2019-12-27 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 2,022 disposed | 10.48 | 21,190.56 | Form 4, filing 0001104659-20-000980 | |
| 2019-12-26 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 15,494 disposed | 10.75 | 166,560.50 | Form 4, filing 0001104659-20-000980 | |
| 2019-12-24 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 24,477 disposed | 10.97 | 268,512.69 | Form 4, filing 0001104659-20-000980 | |
| 2019-12-23 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 4,319 disposed | 10.58 | 45,695.02 | Form 4, filing 0001104659-20-000980 | |
| 2019-06-26 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 12,508 disposed | 14.77 | 184,743.16 | Form 4, filing 0001104659-19-038310 | |
| 2019-06-25 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 25,500 disposed | 15.07 | 384,285.00 | Form 4, filing 0001104659-19-038310 | |
| 2019-06-24 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 9,107 disposed | 15.49 | 141,067.43 | Form 4, filing 0001104659-19-038310 | |
| 2019-05-14 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 25,817 disposed | 14.27 | 368,408.59 | Form 4, filing 0001104659-19-030357 | |
| 2019-03-12 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 981 disposed | 11.04 | 10,830.24 | Form 4, filing 0001104659-19-015344 | |
| 2019-03-11 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 25,101 disposed | 11.11 | 278,872.11 | Form 4, filing 0001104659-19-015344 | |
| 2019-03-07 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 2,995 disposed | 11.36 | 34,023.20 | Form 4, filing 0001104659-19-013684 | |
| 2019-02-25 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 10,557 disposed | 12.05 | 127,211.85 | Form 4, filing 0001104659-19-011257 | |
| 2019-01-08 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 13,547 disposed | 10.15 | 137,502.05 | Form 4, filing 0001104659-19-001650 | |
| 2018-11-26 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 26,296 disposed | 11.85 | 311,607.60 | Form 4, filing 0001104659-18-070899 | |
| 2018-03-13 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 12,746 disposed | 16.82 | 214,387.72 | Form 4, filing 0001104659-18-017586 | |
| 2018-03-12 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 13,942 disposed | 17.18 | 239,523.56 | Form 4, filing 0001104659-18-017586 | |
| 2018-03-12 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 3,299 disposed | 18.24 | 60,173.76 | Form 4, filing 0001104659-18-017586 | |
| 2018-03-07 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 3,027 disposed | 16.55 | 50,096.85 | Form 4, filing 0001104659-18-016434 | |
| 2018-02-27 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 5,726 disposed | 17.26 | 98,830.76 | Form 4, filing 0001104659-18-013695 | |
| 2018-02-26 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 5,300 disposed | 17.61 | 93,333.00 | Form 4, filing 0001104659-18-013695 | |
| 2018-02-15 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 1,851 disposed | 15.67 | 29,005.17 | Form 4, filing 0001104659-18-010450 | |
| 2018-01-08 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 14,040 disposed | 13.93 | 195,577.20 | Form 4, filing 0001104659-18-002137 | |
| 2017-12-18 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 40 disposed | 14.75 | 590.00 | Form 4, filing 0001104659-17-074139 | |
| 2017-12-15 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 11,943 disposed | 14.18 | 169,351.74 | Form 4, filing 0001104659-17-074139 | |
| 2017-03-07 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 2,342 disposed | 8.16 | 19,110.72 | Form 4, filing 0001104659-17-015592 | |
| 2017-02-28 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 4,027 disposed | 7.01 | 28,229.27 | Form 4, filing 0001104659-17-013194 | |
| 2017-02-27 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 4,000 disposed | 6.97 | 27,880.00 | Form 4, filing 0001104659-17-013194 | |
| 2017-02-16 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 1,508 disposed | 6.42 | 9,681.36 | Form 4, filing 0001104659-17-010293 | |
| 2017-01-10 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 9,110 disposed | 13.82 | 125,900.20 | Form 4, filing 0001104659-17-002351 | |
| 2016-03-08 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 2,412 disposed | 5.34 | 12,880.08 | Form 4, filing 0001104659-16-104300 | |
| 2016-02-17 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 1,503 disposed | 4.54 | 6,823.62 | Form 4, filing 0001104659-16-098576 | |
| 2015-03-19 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 17,307 disposed | 16.43 | 284,354.01 | Form 4, filing 0001104659-15-021403 | |
| 2015-02-18 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 1,593 disposed | 14.02 | 22,333.86 | Form 4, filing 0001104659-15-012683 | |
| 2014-09-02 |
Stemline Therapeutics Inc STML |
P, Open-market purchase | 2,000 acquired | 10.99 | 21,975.40 | Form 4, filing 0001104659-14-064491 | |
| 2014-05-21 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 15,250 disposed | 13.32 | 203,130.00 | Form 4, filing 0001104659-14-041435 | |
| 2013-11-27 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 15,411 disposed | 19.91 | 306,833.01 | Form 4, filing 0001104659-13-087577 | |
| 2013-11-26 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 3,144 disposed | 21.27 | 66,872.88 | Form 4, filing 0001104659-13-087577 | |
| 2013-11-25 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 14,350 disposed | 21.94 | 314,839.00 | Form 4, filing 0001104659-13-087577 | |
| 2013-11-22 |
Stemline Therapeutics Inc STML |
S, Open-market sale | 11,523 disposed | 20.14 | 232,073.22 | Form 4, filing 0001104659-13-087577 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 2
- Open-market sale 43
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Hoberman Kenneth, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001573722
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6